Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2007
03/14/2007CN1928083A Mononucleotide polymorphism of human heterogenous substance metabolism enzyme gene and application of diagnosing and treating large intestinal cancer
03/14/2007CN1928082A Expression sequence label for specific expressing in human liver
03/14/2007CN1928069A Streptomycete and application thereof
03/14/2007CN1927887A Anti-rabies virus recombination immune toxin and preparation process
03/14/2007CN1927883A 新的细胞因子zalpha11配体 New cytokine zalpha11 Ligand
03/14/2007CN1927882A Sugar conjugated protein with resistant action of human acquired immunity system synthesis disease virus activity
03/14/2007CN1927877A siRNA for inhibiting human Ezrin gene expression and expression carrier thereof
03/14/2007CN1927466A Array plate and manufacturing process for array plate assembly
03/14/2007CN1927405A Combination immunizing preparation comprising recombinant plasmid and duplicate deficit type recombinant adenovirus
03/14/2007CN1927402A Construction and preparation of tumor target gene transmission non-viral vector
03/14/2007CN1927394A Oral administration recombinant helicobacterpylori vaccine and preparing method thereof
03/14/2007CN1927386A Application of NYGGF5 protein and encoding gene thereof in preparation of medicine for inhibiting adipocyte differentiation
03/14/2007CN1926991A Producing method of gene recombination nucleopolyhedrosis virus pesticide and application thereof
03/14/2007CN1304597C Method and apparatus for amplification of nucleic acid sequences by using thermal convection
03/14/2007CN1304596C Detection system
03/14/2007CN1304595C Analytical method and kit
03/14/2007CN1304581C Compositions and methods for treating neurodegenerative diseases
03/14/2007CN1304580C Surface glucoprotein gp160 of recombination expression human acquired immunity defact virus 1
03/14/2007CN1304579C Recombinant vaccine using flavivirus as vector
03/14/2007CN1304578C Ecdysone receptor-based inducible gene expression system
03/14/2007CN1304577C Cotton glucuronate transferase and coded gene thereof
03/14/2007CN1304576C Regulation of quinolate phosphoribosyl transferase expression
03/14/2007CN1304574C Recombination human erythropoietin gene suitable for pronucleus expression system and its expression carrier
03/14/2007CN1304573C NDRG2 and NDRG4 protein and their use for diagnosing and suppressing tumour
03/14/2007CN1304572C Modified antisense nucleotides complementary to section of human Ha-Ras gene
03/14/2007CN1304571C Method for breeding transgenic zebra fish and its special plasmid
03/14/2007CN1304570C Allene oxide synthase and divinyl ether synthase from the C Y P 7 4-enzyme family isolated out of physcomitrella patens, the nucleotide sequences that code these synthases, and method for producing pa
03/14/2007CN1304569C Subtilase enzymes of the I-S1 and I-S2 sub-groups having an additional amino acid residue in an active site loop region
03/14/2007CN1304568C Novel human complement C1r-like serine proteinase analogue, and its encoding sequence and use
03/14/2007CN1304567C Method and compositions useful for modulation of angiogenesis using tyrosine kinase SRC
03/14/2007CN1304559C Oncolytic microorganism expressing heat shock protein and its application
03/14/2007CN1304427C Angiogenesis inhibiting fusion protein and its use
03/14/2007CN1304426C Signal system and elements used therein
03/14/2007CN1304425C Fusion protein containing soluble tumor necrosis factor II type receptor and interleukin I receptor agonist IL1Ra its preparation process and medicine composition
03/14/2007CN1304422C Non-amidated omega-conotoxin VIIA and its prepn process and application
03/14/2007CN1304416C Heterocyclic tripeptides as hepatitis C inhibitors
03/14/2007CN1304411C Saltant dihydrofolic acid reductase gene and application in mammal cell gene expression thereof
03/14/2007CN1304410C Tumor necrosis factor-Gamma
03/14/2007CA2558601A1 Substance carrier using hollow nanoparticle of hepatitis b virus protein and liposome, and method of introducing substance into cell
03/13/2007US7189940 Plasma-assisted melting
03/13/2007US7189903 Desirable traits include greater yield, better stalks, better roots, resistance to insecticides, herbicides, pests, and disease, tolerance to heat and drought, reduced time to crop maturity, better agronomic quality, higher nutritional value, and uniformity in germination times
03/13/2007US7189902 Desirable traits may include resistance to diseases and insects, tolerance to heat and drought, reducing the time to crop maturity, greater yield, and better agronomic quality
03/13/2007US7189899 Soybean variety XB38T05
03/13/2007US7189898 Seed of a soybean variety designated 0120115; hybrid soybean seeds and plants produced by crossing the cultivar 0120115 with another soybean cultivar; tissue cultures of regenerable cells; higher seed yield, resistance to diseases and insects, better stems and roots, tolerance to drought and heat
03/13/2007US7189895 Increasing flavonoid production in soy bean plants; food processing; nutrients; beverages
03/13/2007US7189894 Nucleotide sequences coding enzymatic polypeptide for use in the generation of gamma linolenic acid
03/13/2007US7189893 Trangenic plants coding nucleotide sequences which are associated with abiotic stress responses and abiotic stress tolerance in plants; genetic engineering and drought, freeze and heat resistance
03/13/2007US7189892 Nucleic acids encoding phloem small RNA-binding proteins and transgenic plants comprising them
03/13/2007US7189891 Isolated ferric reductase defective polypeptides and uses thereof
03/13/2007US7189890 Comprises DNA sequences associated with propagation, culturing and cloning of rice, maize, barley and/or wheat
03/13/2007US7189889 Adjusting seed phenotype in plants; obtain cells, transform with vector, recover transformed cells, propagate, mointor phenotype of aleurone cells
03/13/2007US7189842 A relaxed oriented plastic substrate with reactants and labels directly attached at binding sites where the structures of the reactants are identifiable by their discrete location; the label amount is proportional to the amount of reactant; increase detection signal strength; high surface area; kinetics
03/13/2007US7189840 Oncosuppressive gene
03/13/2007US7189839 An isolated polynucleotide that encodes a polypeptide comprising an amino acid sequence that represents the extracellular domain, also called a cytokine-binding domain, of a new human soluble class II cytokine receptor designated Zcytor16; antiarthritic and -inflammatory agents; autoimmune diseases
03/13/2007US7189838 PRO9834 nucleic acids
03/13/2007US7189837 Cell surface molecule-induced macrophage activation
03/13/2007US7189836 Nucleic acids encodingβ 1,4-N-acetylgalactosaminyltransferases from C. jejuni
03/13/2007US7189835 Which allows use of Pichia as host cells for producing large amounts of recombinant proteins
03/13/2007US7189830 Anti-KSA/IL-2 fusion proteins with reduced immunogenicity
03/13/2007US7189827 Fusion of Fc domains with biologically active peptides and a process for preparing pharmaceutical agents using biologically active peptides; recombinant proteins
03/13/2007US7189826 Hybridomas cell lines; viricides
03/13/2007US7189823 Monoclonal antibody useful in the diagnosis of proliferative disorders of the colon such as colon cancer; ILLFDYFNR is a colon cancer antigen sequence
03/13/2007US7189820 Antibody for use in the treatment, prevention and diagnosis of cancer, autoimmune, arthritic and graft vs. host diseases
03/13/2007US7189819 Humanized antibodies that recognize beta amyloid peptide
03/13/2007US7189816 Antibody having a binding structure comprising specified complementarity determining region (CDR) sequences for a target tumor antigen on human gastrointestinal epithelial tumour cells; colon cancer diagnosis or immunotherapy
03/13/2007US7189813 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
03/13/2007US7189812 Comprises maternal protein (MATER) for treatment of infertility and reduced fertility; contraceptives
03/13/2007US7189809 Genetic engineered ioslated polynucleotide; anticholesterol agents, Alzheimer's disease, antilipemic agents
03/13/2007US7189808 Use of carboxy-terminal fragment of Ki-67 protein or of an active part, fragment or homologue thereof as compound that can be used for intracellular transfer and for introduction into and release by cells; antiinflammatory, anticancer agents
03/13/2007US7189807 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
03/13/2007US7189805 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2007US7189801 Peptides and peptidomimetics with structural similarity to human p53 that activate p53 function
03/13/2007US7189800 Forming vaccines; analyzing hemagglutinin, calibration
03/13/2007US7189705 Methods of enhancing SPLP-mediated transfection using endosomal membrane destabilizers
03/13/2007US7189696 Peptide antagonists of zonulin and methods for use of the same
03/13/2007US7189695 Detecting ligands that stimulate proliferation and/or development of hematopoietic, lymphoid and myeloid cells in vitro and in vivo
03/13/2007US7189690 Administering an albumin fusion protein comprising two or more tandemly oriented GLP-1 polypeptides, wherein (i) said GLP-1 polypeptides are selected from wild-type GLP-1 fragments, and GLP-1 variants, fused to albumin
03/13/2007US7189689 Apolipoprotein A-L agonists and their use to treat dyslipidemic disorders
03/13/2007US7189570 Putrescine-n-methyltransferase promoter
03/13/2007US7189566 Nucleotide sequences coding polypeptide for use in the treatment of bone, arthritic, inflammatory, fertility and atherosclerotic disorders
03/13/2007US7189565 Comprises polypeptide associated with urogenital system for detection, prevention and treatment of cancer
03/13/2007US7189564 PRO1335 nucleic acids
03/13/2007US7189563 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2007US7189562 Mononuclear phagocytes in therapeutic drug delivery
03/13/2007US7189561 Production of adenovirus vectors with reduced levels of replication competent adenovirus contamination
03/13/2007US7189559 Nucleic acid; alters quantity of oil in bacteria, yeast such as Yarrowia, algae and fungi; genetic engineering
03/13/2007US7189557 Fermentation for high cell density culture; thrombolytic agents; genetically engineered plasmid carries kanamycin resistant marker
03/13/2007US7189555 Proteases from gram-positive organisms
03/13/2007US7189553 Modified subtilisins and detergent, compositions containing same
03/13/2007US7189552 Thermostable alpha-amylases
03/13/2007US7189551 Human RPS6KA6-related gene variant associated with lung cancers
03/13/2007US7189550 Producing a galactose-containing complex carbohydrate by culturing a transformant containing recombinant DNA to obtain protein with beta 1,3-galactosyltransferase activity using uridine-5'-diphosphogalactose as an enzyme source and an acceptor
03/13/2007US7189549 Recombinant polynucleotides encoding pro-geldanamycin producing polyketide synthase and accessory proteins, and uses thereof
03/13/2007US7189548 Enhanced sarcosine oxidase for use in measurement of creatinine concentration in human serum or urine; diagnosing renal disorders
03/13/2007US7189546 Polypeptide, cDNA encoding the same, and use of them
03/13/2007US7189542 Drosophila clipped FRT (cFRT) chromosome insensitive to P transposase, generating method thereof, and application thereof
03/13/2007US7189540 Optimized recognition site of the alphavirus non-structural protease for tag removal and specific processing of recombinant proteins
03/13/2007US7189539 Polypeptides, fragments and homologues; vectors, host cells, antibodies; genetic engineering and expression; treatment of urogenital, sexual, metabolic, inflammatory, pregnancy, and g-protein coupled receptor disorders; drug screening
03/13/2007US7189538 Comprises polypeptide associated with hyphal branching for use in controlling hyphal morphology and fungal viscosity/propagation in culture; heterologous gene expression and bioreactors
03/13/2007US7189537 Comprises oncogenic nucleotide sequences for use in diagnosis, prevention and treatment of various cancers; gene therapy and antisense agents